Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis J Rosebraugh

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Economics|January 4, 2003
How I got through to Kari's motherCurtis J Rosebraugh
JAMA|May 24, 2017
Dosing of Etelcalcetide and Cinacalcet for Secondary HyperparathyroidismMary T Thanh Hai, Jean-Marc Guettier, Curtis J Rosebraugh
CNS Neuroscience & Therapeutics|April 27, 2012
Reanalysis of methamphetamine dependence treatment trialCelia Winchell, Bob A Rappaport, Rigoberto Roca, et al.
Advances in Health Sciences Education : Theory and Practice|October 19, 2002
Global Ratings of Student Performance in a Standardized Patient Examination: Is the Whole More than the Sum of the Parts?David J. Solomon, Karen Szauter, Curtis J. Rosebraugh, et al.
Chest|October 14, 2003
Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a dayMary E Purucker, Curtis J Rosebraugh, Feng Zhou, et al.
Chest|January 2, 2013
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experienceAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Chest|October 2, 2013
ResponseAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Annals of the American Thoracic Society|October 12, 2017
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical TrialAnthony G Durmowicz, Robert Lim, Hobart Rogers, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
Centers for education and research on therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United StatesCurtis J Rosebraugh, Peter K Honig, Sally Usdin Yasuda, et al.
The New England Journal of Medicine|December 16, 2011
The risks and benefits of indacaterol--the FDA's reviewBadrul A Chowdhury, Sally M Seymour, Theresa M Michele, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Economics|January 4, 2003
How I got through to Kari's motherCurtis J Rosebraugh
JAMA|May 24, 2017
Dosing of Etelcalcetide and Cinacalcet for Secondary HyperparathyroidismMary T Thanh Hai, Jean-Marc Guettier, Curtis J Rosebraugh
CNS Neuroscience & Therapeutics|April 27, 2012
Reanalysis of methamphetamine dependence treatment trialCelia Winchell, Bob A Rappaport, Rigoberto Roca, et al.
Advances in Health Sciences Education : Theory and Practice|October 19, 2002
Global Ratings of Student Performance in a Standardized Patient Examination: Is the Whole More than the Sum of the Parts?David J. Solomon, Karen Szauter, Curtis J. Rosebraugh, et al.
Chest|October 14, 2003
Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a dayMary E Purucker, Curtis J Rosebraugh, Feng Zhou, et al.
Chest|January 2, 2013
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experienceAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Chest|October 2, 2013
ResponseAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Annals of the American Thoracic Society|October 12, 2017
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical TrialAnthony G Durmowicz, Robert Lim, Hobart Rogers, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
Centers for education and research on therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United StatesCurtis J Rosebraugh, Peter K Honig, Sally Usdin Yasuda, et al.
The New England Journal of Medicine|December 16, 2011
The risks and benefits of indacaterol--the FDA's reviewBadrul A Chowdhury, Sally M Seymour, Theresa M Michele, et al.
Pageof 2